These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 8377628

  • 21. [Angiotensin converting enzyme inhibitors in arterial hypertension].
    Ramón González-Juanatey J.
    Rev Esp Cardiol; 1999; 52 Suppl 3():73-8. PubMed ID: 10614152
    [Abstract] [Full Text] [Related]

  • 22. Optimal medical management of peripheral arterial disease.
    Rice TW, Lumsden AB.
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [Abstract] [Full Text] [Related]

  • 23. Renal effects of angiotensin-converting enzyme inhibitors that result in cost savings and improved patient outcomes.
    Swislocki AL, Siegel D.
    Am J Manag Care; 2001 Mar; 7(3):283-95. PubMed ID: 11258145
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The role of ACE inhibitors in the management of hypertension.
    Ramsay LE, Yeo WW.
    J Hum Hypertens; 1990 Oct; 4 Suppl 4():1-4; discussion 4-5. PubMed ID: 2283649
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH.
    Med Klin (Munich); 2003 Dec 15; 98(12):771-5. PubMed ID: 14685679
    [Abstract] [Full Text] [Related]

  • 29. [Isolated systolic hypertension in the elderly].
    Gareri P, Olivo M, Ciotti D, Ritacco AR, Rotundo A, Berardelli M, Mattace R.
    Minerva Med; 2001 Dec 15; 92(6):453-72. PubMed ID: 11740433
    [Abstract] [Full Text] [Related]

  • 30. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
    He H, Li LM, Cao WH, Sun NL, Liu MZ, Hu YH.
    Ann Hum Biol; 2005 Dec 15; 32(1):30-43. PubMed ID: 15788353
    [Abstract] [Full Text] [Related]

  • 31. Age-related effects of converting enzyme inhibitors: a commentary.
    Ball SG.
    J Cardiovasc Pharmacol; 1988 Dec 15; 12 Suppl 8():S105-8. PubMed ID: 2469890
    [Abstract] [Full Text] [Related]

  • 32. [More or less lowering of blood pressure? Antihypertensive therapy with ACE inhibitors].
    Fortschr Med Suppl; 1990 Dec 15; 84():1-14. PubMed ID: 2338324
    [No Abstract] [Full Text] [Related]

  • 33. [Practical questions about therapy of hypertension with ACE inhibitors. J. Scholze, Berlin, on the 24-hour effect, possible combinations and side-effects of ACE inhibitors--ASS/antirheumatic agents].
    Scholze J.
    Fortschr Med; 1995 Feb 10; 113(4):51-4. PubMed ID: 7713469
    [No Abstract] [Full Text] [Related]

  • 34. Renoprotective effect of ACE inhibitors: dissecting the molecular clues and expanding the blood pressure goal.
    Remuzzi G.
    Am J Kidney Dis; 1999 Nov 10; 34(5):951-4. PubMed ID: 10561156
    [No Abstract] [Full Text] [Related]

  • 35. Critical assessment of ACE inhibitors. Part 1.
    Howes LG.
    Aust Fam Physician; 1995 Mar 10; 24(3):425-9. PubMed ID: 7717908
    [Abstract] [Full Text] [Related]

  • 36. Differences Among ACE Inhibitors.
    Kostis JB.
    Am J Hypertens; 2010 Nov 10; 23(11):1156. PubMed ID: 20956961
    [No Abstract] [Full Text] [Related]

  • 37. Present aspects and future developments with ACE inhibitors.
    Reid JL.
    Cardiology; 1989 Nov 10; 76 Suppl 2():1-10. PubMed ID: 2670216
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Introduction: actions of ACE inhibitors in hypertension--broader than blood pressure control.
    Jennings GL.
    J Hum Hypertens; 1994 Sep 10; 8 Suppl 1():S1-2. PubMed ID: 7807507
    [No Abstract] [Full Text] [Related]

  • 40. [Angiotensin converting enzyme inhibitors: drug of first or second choice in hypertension in advanced age].
    Spławinski J, Kwolek A.
    Kardiol Pol; 1993 Aug 10; 39(8):152-4, comment 155-6. PubMed ID: 8231008
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.